Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Evaric Pharmaceuticals Inc.
FDA Inspection
•Evaric Pharmaceuticals Inc.•May 16, 2025

Evaric Pharmaceuticals Inc. – FDA Inspection, May 16, 2025

Record Details

This FDA Inspection record concerns Evaric Pharmaceuticals Inc., with an inspection on May 16, 2025, issued by the New York District Office, covering human drugs.

Company
Evaric Pharmaceuticals Inc.
Inspection Date
May 16, 2025
Product Type
Human Drugs
Office
New York District Office
People
  • Bijoy Panicker
  • Luxuly Abraham (Issuing Officer)
View Company Profile

ID · 3909e477-38cc-417f-888c-e683286c4897

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1270045
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

4
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.42(c)Defined areas of adequate size for operations
  4. FDCA 582(b)(4)Systems in place to comply with verification requirements

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Evaric Pharmaceuticals Inc.

2
DateClassificationOfficeProject area
May 29, 2019Not classifiedNew York District Office
February 7, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Evaric Pharmaceuticals Inc.
  • FDA Inspection 1091300 - 2019-05-29
  • FDA Inspection 999784 - 2017-02-07

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Evaric Pharmaceuticals Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.